1. Viability of pathogenic dermatophytes during a 4-week treatment with 1% topical luliconazole for tinea pedis.
- Author
-
Iwanaga T, Ushigami T, Anzawa K, and Mochizuki T
- Subjects
- Administration, Topical, Aged, Aged, 80 and over, Arthrodermataceae genetics, DNA, Intergenic genetics, Female, Humans, Imidazoles administration & dosage, Imidazoles therapeutic use, Male, Middle Aged, Tinea Pedis microbiology, Treatment Outcome, Antifungal Agents therapeutic use, Arthrodermataceae drug effects, Arthrodermataceae pathogenicity, Microbial Viability drug effects, Tinea Pedis drug therapy
- Abstract
The viability of pathogenic fungi in the scale was investigated during topical administration of 1% luliconazole (LLCZ). Thirteen tinea pedis patients found to be positive on KOH examination were assessed by mycological examinations and quantitative real-time polymerase chain reaction (PCR) targeted internal transcribed spacer (ITS) in ribosomal RNA gene at the initial visit and after 2 and 4 weeks of treatment. Assays showed that the average copy number of ITS DNA had significantly decreased to 22.9% at 2 weeks and 4.8% at 4 weeks compared with the initial visit. LLCZ topical treatment could defeat almost pathogenic dermatophytes in the scales within 4 weeks., (© The Author(s) 2019. Published by Oxford University Press on behalf of The International Society for Human and Animal Mycology.)
- Published
- 2020
- Full Text
- View/download PDF